Crohn's disease, ulcerative colitis, immunity, regenerative treatment
What kind of disease is Crohn's disease and ulcerative colitis?
Limitations of existing treatments and differences between LACELLIC
Why LACELLIC Hybrid Care is different
LACELLIC EvoNK + EvoStem combination package
The key to intestinal disease immunity and regeneration proposed by LACELLIC
LACELLIC Bowel Disease Medical Tour
LACELLIC Medical Tour Package Crohn's disease and ulcerative colitis are known as autoimmune diseases that cause chronic inflammation and ulceration of the digestive tract mucosa.
In the beginning, it may be easy to overlook because it feels like simple digestive discomfort or a temporary change in bowel habits, but as it progresses, repeated abdominal pain, diarrhea, bloody stool, weight loss, and chronic fatigue may appear.
In particular, because the symptoms repeatedly worsen and then improve, there are many cases where the improved period is accepted as recovery and passes.
However, the disease cannot be diagnosed based on these symptoms alone. Confirmation through endoscopy, imaging tests, blood tests, etc. and treatment by medical staff should be given priority. Methods that have been considered together so far
Drug treatments such as steroids, immunosuppressants, and biological agents are widely used for inflammatory bowel disease, and surgical treatment may also be considered depending on the condition.
These treatments play an important role in controlling inflammation and managing symptoms and are planned and followed at the discretion of your healthcare provider.
On the other hand, research continues on approaches that look at both the malfunctioning immune response itself and the intestinal mucosa damaged by ulcers. Immune cells and stem cells in our body - LACELLIC’s unique EvoNK·EvoStem hybrid
NK cells are immune cells that originally exist in our body and are known to play a role in recognizing abnormal cells and regulating immune responses.
Stem cells are cells with the ability to differentiate into various types of cells, and have been studied for a long time in relation to the environment in which damaged tissues are restored.
LACELLIC's EvoNK·EvoStem Hybrid is a program that combines these two. It consists of EvoNK, which regulates the immune response, and EvoStem, which monitors the regenerative environment of the entire body, including digestive tissue, through a combined intravenous (IV) method.
Here are the points we see together in the program:
• Block chronic inflammatory signals in the intestines • Regenerate damaged intestinal mucosa and cells • Induce tolerance in malfunctioning immune cells • Block the cycle of deterioration/improvement and recurrence
It is designed from the perspective of re-establishing immune balance (tolerance) rather than simply suppressing immunity.
However, for inflammatory bowel disease, the application and method vary depending on the type of disease, extent of involvement, and the current systemic condition of the drug treatment already received.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
The priority is to continue the standard treatment and regular follow-up currently in progress at the discretion of the medical staff in charge, and the cell program is not a replacement for this.
Do not stop taking the medication arbitrarily and be sure to consult your doctor. Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home, and connection to global partner clinics in Southeast Asia, the Middle East, and the Americas are also provided.
The basic schedule is a one-time visit to Korea, from precise diagnosis to cell transplantation, and then repeated visit cycles and ongoing management based on the EvoX platform are reviewed. The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
Treatment effectiveness may vary depending on the individual.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
